Impact on Quality of Life From Multi-modality Lung Cancer
Impact on Quality of Life From Multi-modality Lung Cancer
The investigators aim to explore how lung cancer patients and their family carers are
 affected by different types of cancer treatment. The investigators are focusing on a
 particular type of lung cancer called Stage III N2. N2 means the cancer has spread just
 outside the lung to the lymph nodes. There are two main treatments available in the UK for
 this type of lung cancer:

 1. surgery PLUS chemo radiotherapy or chemotherapy

 2. radiotherapy PLUS chemotherapy Patients live for a similar length of time with either
 treatment option so it is difficult for patients and health professionals to know which
 treatment to choose. It is important to understand the impact of the treatment on
 patients in their daily lives. Patients will be allocated at random to receive one of
 the two treatments options. Patients and carers will complete questionnaires and take
 part in interviews. The results of this study will help the investigators decide if a
 larger study should be conducted in the future.
The investigators aim to explore how lung cancer patients and their family carers are
 affected by different types of cancer treatment.The information collected will help patients
 and their carers in the future to make decisions about the best treatment option for them.
 The investigators are focusing on a particular type of lung cancer called Stage III N2. N2
 means the cancer has spread just outside the lung to the lymph nodes. Around 2500 patients a
 year in the UK are diagnosed with this type of lung cancer. There are two main treatments
 available in the UK:

 1. surgery PLUS chemo radiotherapy or chemotherapy

 2. radiotherapy PLUS chemotherapy Patients live for a similar length of time with either
 treatment option so it is difficult for patients and health professionals to know which
 treatment to choose. Research has not explored how the two different treatments offered
 affect individual patients and their carer. It is important to understand the impact of
 the treatment on:

 -  Symptoms

 -  Side effects

 -  Emotional well-being

 -  Day to day activities

 Other research studies including N2 lung cancer patients have struggled with patient
 recruitment. This study design will show us if it is possible to run this type of research
 with this group of patients. Patients will be allocated at random to receive one of the two
 treatments options: 1) surgery PLUS chemo radiotherapy or chemotherapy 2) radiotherapy PLUS
 chemotherapy Patients and carers will complete questionnaires and take part in interviews.
 Health professionals will also be asked to take part in interviews. These interviews will
 help the investigators to understand their experience of recruiting patients to this study.
 The results of this study will help the investigators decide if a larger study should be
 conducted in the future.
Inclusion Criteria:

 -  Patients with potentially resectable T1-4 N2 M0 NSCLC who have received an multi
 disciplinary team recommendation for multi-modality treatment

 -  Multi disciplinary team consensus that the patient has adequate physiological reserve
 for multi-modality treatment and either treatment arm is both technically and
 clinically appropriate

 -  Patient over the age of 18 years

 Carer criteria:

 -  Carers of patients who have consented to take part in the randomised controlled trial

 -  Over the age of 18 years

 Exclusion Criteria:

 -  Patients unable to provide informed consent

 -  Patients who are not able to read and understand English